Skip to content

Search

Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: Advantages, limitations, and comparisons with laboratory-based testing

Type 1 diabetes is well-recognised as a continuum heralded by the development of islet autoantibodies, progression to islet autoimmunity causing beta cell destruction, culminating in insulin deficiency and clinical disease. Abnormalities of glucose homeostasis are known to exist well before the onset of typical symptoms.

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.

Participant and caregiver perspectives on health feedback from a healthy lifestyle check

The usual output following health consultations from paediatric services is a clinical letter to the referring professional or primary care provider, with a copy sent to the patient's caregiver. There is little research on how patients and caregivers perceive the letter content.

School experience studies

Besides the challenges associated with their teenage years, adolescents with Type 1 Diabetes (T1D) encounter additional challenges of having a chronic condition.

CGM with remote monitoring makes for happy families

Parents of young children with type 1 diabetes experience significantly better quality of life and reduced fear of hypoglycaemic episodes when given remote access to their child's continuous glucose monitoring, new Children's Diabetes Centre research has found.

2018 workshop recap

The Children’s Diabetes Centre’s (CDC) annual workshop provided a great opportunity for diabetes researchers to get together in the one venue to showcase their work recently.

Animas pump offer

Insulin pump company Ypsomed Australia has announced an offer for families currently using an Animas Vibe.

Sightseeing and study on Swedish students' agenda

Meet Charlotta Swenson Backelin and Louise Haggendal. The medical students, from the University of Gothenburg in Sweden, have spent the past two months helping the The Kids’ Children’s Diabetes Centre conduct exercise research as part of their degrees.

Gifted pump proves a life changer for family

Oliver Bowman is too young to understand the enormity of having type 1 diabetes but his young parents Brooke and Aidan know all too well the reality of having a child with a chronic disease.

The diabetes trial changing lives

Seventeen-year-old Andrew says he has a better handle on managing his type 1 diabetes since taking part in an at-home research trial involving a sophisticated new pump system. Watch Andrew, his mum Leeanne and The Kids researcher Professor Tim Jones discuss the trial on Today Tonight.